Pressure BioSciences, Inc. (PBIO) Corporate Media Kit

• Mr. Richard T. Schumacher, President & CEO Boston Biomedica (CEO, Founder); Panacos Pharma (President, Co-founder); Trinity Biotech (Founding Group); CBR Labs (Gen’l Mgr) - Harvard Medical School • Dr. Edmund Y. Ting, Senior VP of Engineering Avure Technologies (CTO); Flow Int’l (VP R&D); Grumman Aerospace; Pioneer in High Pressure Processing for “Clean Label”, Safe Food; MIT (Ph.D.) • Dr. Alexander V. Lazarev, Senior VP and CSO Proteome Systems; Genomic Solutions; ESA; University of Kazan (Ph.D.) • Dr. Alexander V. Lazarev, Senior VP and CSO Proteome Systems; Genomic Solutions; ESA; University of Kazan (Ph.D.) • Dr. Nathan Lawrence, Senior Advisor (recently retired VP of S&M at PBI) Becton Dickinson, Boston Biomedica, 454 Life Sciences, Pressure BioSciences, Inc. Board • Jeffrey Peterson, MS Board Chairman • Kevin Pollack, Esq., MBA Chairman: Audit Committee • Vito Mangiardi, MBA Chairman: Compensation Committee • Mickey Urdea, Ph.D. Chairman: SAB • Richard T. Schumacher CEO, Treasurer, Clerk 4 COMPANY MANAGEMENT (OTCQB: PBIO)

RkJQdWJsaXNoZXIy NDMyMDk=